Need professional-grade analysis? Visit stockanalysis.com
$1.45B
N/A
N/A
N/A
Procept Biorobotics Corp (PRCT) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $24.76, down 1.51% from the previous close.
Over the past year, PRCT has traded between a low of $22.69 and a high of $65.05. The stock has lost 53.1% over this period. It is currently 61.9% below its 52-week high.
Procept Biorobotics Corp has a market capitalization of $1.45B.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Side-by-side comparison against top Healthcare peers.